The company today announced it has scheduled four additional symposiums in Los Angeles, Dallas, Washington DC, and Boston through September.
Early studies show significant improvements in treatment response.
It clearly demonstrates that a growing number of medical professionals see real potential in IMRT for improving patient care, treatment efficacy, and cancer outcomes. The symposiums feature leading clinicians who discuss their experience with IMRT as well as numerous aspects of the technique, including patient selection, treatment planning, dose calculations, and quality assurance. Varian Medical Systems employs approximately 2,300 people who are located at manufacturing sites in North America, Europe and in its 40 sales and support offices around the world. Inc. All rights reserved. Reproduction of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.